Axa’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-732,229
Closed -$50.5M 319
2025
Q2
$50.5M Sell
732,229
-18,666
-2% -$1.22M 0.15% 145
2025
Q1
$50.9M Sell
750,895
-320,064
-30% -$19.2M 0.17% 122
2024
Q4
$48.1M Buy
1,070,959
+337,738
+46% +$18.9M 0.15% 140
2024
Q3
$46.1M Buy
733,221
+29,040
+4% +$1.69M 0.14% 154
2024
Q2
$41.6M Sell
704,181
-235,689
-25% -$14.7M 0.12% 164
2024
Q1
$75M Buy
939,870
+1,021
+0.1% +$78K 0.22% 101
2023
Q4
$74.1M Sell
938,849
-3,032
-0.3% -$216K 0.24% 99
2023
Q3
$65.8M Buy
941,881
+76,020
+9% +$5.39M 0.23% 104
2023
Q2
$59.9M Sell
865,861
-165,646
-16% -$11.8M 0.2% 119
2023
Q1
$76.7M Buy
1,031,507
+35,581
+4% +$2.98M 0.26% 95
2022
Q4
$92.8M Sell
995,926
-29,595
-3% -$2.86M 0.33% 77
2022
Q3
$97.8M Buy
1,025,521
+511,706
+100% +$50.7M 0.38% 57
2022
Q2
$47.6M Buy
513,815
+246,790
+92% +$24.1M 0.18% 140
2022
Q1
$27M Buy
267,025
+18,125
+7% +$1.9M 0.08% 288
2021
Q4
$25.7M Sell
248,900
-79,375
-24% -$7.33M 0.07% 312
2021
Q3
$27.9M Buy
328,275
+51,534
+19% +$4.32M 0.08% 280
2021
Q2
$23.1M Sell
276,741
-287,186
-51% -$23.5M 0.07% 314
2021
Q1
$42.4M Buy
563,927
+21,523
+4% +$1.57M 0.13% 205
2020
Q4
$37M Sell
542,404
-48,987
-8% -$3.19M 0.12% 202
2020
Q3
$34.5M Sell
591,391
-17,119
-3% -$1.07M 0.12% 185
2020
Q2
$39.5M Buy
608,510
+82,127
+16% +$5.17M 0.16% 149
2020
Q1
$31.2M Buy
526,383
+79,953
+18% +$5.34M 0.16% 157
2019
Q4
$33.2M Sell
446,430
-9,240
-2% -$649K 0.13% 191
2019
Q3
$28.7M Sell
455,670
-46,484
-9% -$2.75M 0.11% 231
2019
Q2
$27.4M Sell
502,154
-2,559
-0.5% -$138K 0.11% 249
2019
Q1
$27.2M Sell
504,713
-93,819
-16% -$5.79M 0.11% 235
2018
Q4
$39.2M Buy
598,532
+25,369
+4% +$1.89M 0.17% 157
2018
Q3
$45.1M Buy
573,163
+71,642
+14% +$5.12M 0.17% 166
2018
Q2
$32.3M Sell
501,521
-22,994
-4% -$1.52M 0.12% 212
2018
Q1
$32.6M Sell
524,515
-112,966
-18% -$8.11M 0.13% 196
2017
Q4
$46.2M Sell
637,481
-43,771
-6% -$3.18M 0.18% 164
2017
Q3
$55.4M Buy
681,252
+87,634
+15% +$6.93M 0.24% 120
2017
Q2
$47.8M Buy
593,618
+58,628
+11% +$4.63M 0.22% 141
2017
Q1
$42M Sell
534,990
-342,125
-39% -$27.3M 0.19% 157
2016
Q4
$69.2M Buy
877,115
+9,430
+1% +$763K 0.32% 80
2016
Q3
$77.2M Buy
867,685
+55,270
+7% +$5.22M 0.34% 77
2016
Q2
$77.8M Buy
812,415
+54,910
+7% +$5.47M 0.35% 73
2016
Q1
$78.6M Sell
757,505
-1,127
-0.1% -$110K 0.35% 66
2015
Q4
$74.2M Sell
758,632
-15,015
-2% -$1.47M 0.32% 75
2015
Q3
$74.6M Buy
773,647
+121,545
+19% +$12.8M 0.31% 89
2015
Q2
$68.4M Sell
652,102
-230,628
-26% -$23.6M 0.27% 103
2015
Q1
$91.1M Sell
882,730
-116,028
-12% -$11.7M 0.38% 63
2014
Q4
$96.2M Sell
998,758
-926,840
-48% -$81.7M 0.39% 64
2014
Q3
$153M Sell
1,925,598
-76,412
-4% -$6.02M 0.66% 28
2014
Q2
$151M Sell
2,002,010
-8,383
-0.4% -$634K 0.63% 34
2014
Q1
$150M Sell
2,010,393
-1,018,622
-34% -$72M 0.65% 32
2013
Q4
$217M Sell
3,029,015
-129,569
-4% -$8.33M 0.97% 12
2013
Q3
$179M Sell
3,158,584
-118,383
-4% -$7.05M 0.88% 17
2013
Q2
$187M Buy
+3,276,967
New +$190M 1% 16

Other funds holding CVS

Axa's CVS Position: Q3 2025 in Review

Axa sold out of CVS Health (CVS) in Q3 2025, closing a stake of 732,229 shares — an estimated $50.5M sold.

Axa first reported a position in CVS in Q2 2013 and held it in 49 quarters. The position peaked at $217M in Q4 2013. 1,835 funds tracked by Wall St. Rank hold CVS as of Q3 2025.

  • Axa reported no remaining CVS Health position as of Q3 2025 after selling out during the quarter.
  • Axa sold 732,229 CVS Health shares in Q3 2025, an estimated $50.5M.
  • Axa first reported a position in CVS Health in Q2 2013 and held it in 49 quarters.
  • Axa's CVS Health position peaked at $217M in Q4 2013.
  • 1,835 funds tracked by Wall St. Rank held CVS Health as of Q3 2025.

Based on Axa's 13F filing for Q3 2025, filed 14 Nov 2025.